Selective inhibition of protease-activated receptor 4-dependent platelet activation by YD-3

Thrombosis and Haemostasis

Volumn 87, Issue 6, 2002, Pages 1026-1033

  Wu, Chin Chung ^a   Hwang, Tsong Long ^a   Liao, Chang Hui ^a   Kuo, Sheng Chu ^a   Lee, Fang Yu ^a   Lee, Chun Yann ^a   Teng, Che Ming ^a  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

Platelet activation; Protease activated receptor; YD 3

Indexed keywords

1 BENZYL 3 ETHOXYCARBONYLPHENYLINDAZOLE; 15 HYDROXY 11ALPHA,9ALPHA EPOXYMETHANOPROSTA 5,13 DIENOIC ACID; ANTITHROMBOCYTIC AGENT; CALCIUM ION; CATHEPSIN G; COLLAGEN; FORMYLMETHIONYLLEUCYLPHENYLALANINE; PROCOAGULANT; PROTEINASE ACTIVATED RECEPTOR 1; PROTEINASE ACTIVATED RECEPTOR 1 AGONIST; PROTEINASE ACTIVATED RECEPTOR 4; PROTEINASE ACTIVATED RECEPTOR 4 AGONIST; PROTEINASE ACTIVATED RECEPTOR 4 ANTAGONIST; UNCLASSIFIED DRUG; YD 3; 1 BENZYL 3 (ETHOXYCARBONYLPHENY) INDAZOLE; 1-BENZYL-3-(ETHOXYCARBONYLPHENY)-INDAZOLE; ALANYL TYROSYL PROLYL GLYCYL LYSYL PHENYLALANINE; ALANYL-TYROSYL-PROLYL-GLYCYL-LYSYL-PHENYLALANINE; CATHEPSIN; INDAZOLE DERIVATIVE; OLIGOPEPTIDE; PEPTIDE FRAGMENT; PROTEASE-ACTIVATED RECEPTOR 4; SERINE PROTEINASE; THROMBIN RECEPTOR; THROMBIN RECEPTOR PEPTIDE (42 47); THROMBIN RECEPTOR PEPTIDE (42-47);

AGONIST; ANIMAL CELL; ARTICLE; CALCIUM MOBILIZATION; COMPETITIVE INHIBITION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DESENSITIZATION; DRUG EFFECT; DRUG INHIBITION; DRUG MECHANISM; DRUG SELECTIVITY; HUMAN; HUMAN CELL; IC 50; MOUSE; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION; ANIMAL; CALCIUM SIGNALING; DRUG ANTAGONISM; DRUG INTERACTION; ENZYMOLOGY; PHYSIOLOGY; THROMBOCYTE;

ANIMALS; BLOOD PLATELETS; CALCIUM SIGNALING; CATHEPSINS; DRUG INTERACTIONS; HUMANS; INDAZOLES; MICE; NEUTROPHILS; OLIGOPEPTIDES; PEPTIDE FRAGMENTS; PLATELET ACTIVATION; PLATELET AGGREGATION INHIBITORS; RECEPTORS, THROMBIN; SERINE ENDOPEPTIDASES;

EID: 0036285450     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0037-1613128     Document Type: Article

References (26)

1. Proteinase-activated receptors: Novel mechanisms of signaling by serine proteases
2. Proteinase-activated receptors: New functions for old enzymes
3. How the protease thrombin talks to cells?
4. Molecular cloning of a functional thrombin receptor reveals a novel proteolytic mechanism of receptor activation
5. Antibodies to protease-activated receptor 3 inhibit activation of mouse platelets by thrombin
6. A dual thrombin receptor system for platelet activation
7. Cloning and characterization of human protease-activated receptor 4
8. Molecular cloning of a potential proteinase-activated receptor
9. Synthetic low-molecular weight thrombin inhibitors: Molecular design and pharmacological profile
10. Role of the thrombin receptor in restenosis and atherosclerosis
11. YD-3, a novel inhibitor of protease-induced platelet activation
12. Role of the thrombin receptor in development and evidence for a second receptor
13. Protease-activated receptor 1 and 4 mediate activation of human platelets by thrombin
14. YC-1 inhibited human platelet aggregation through NO-independent activation of soluble guanylate cyclase
15. Quantitative investigations into the aggregation of blood platelets
16. 2+ in platelets and neutrophils
17. Protease-activated receptor 1 and 4 are shutoff with distinct kinetics after activation by thrombin
18. Molecular mechanisms of platelet activation
19. Stimulus-response coupling mechanism
20. PAR3 is a cofactor for PAR4 activation by thrombin
21. Role of thrombin signaling in platelets in haemostasis and thrombosis
22. Cathepsin G activates protease-activated receptor-4 in human platelets
23. Cathepsin G and thrombin: Evidence for two different platelet receptors
24. Cathepsin G is a strong platelet agonist released by neutrophils
25. Platelet activation by fMLP-stimulated polymorphonuclear leukocytes: The activity of cathepsin G is not prevented by antiproteinases
26. Recent advances in platelet-polymorphonuclear leukocyte interaction